 | • レポートコード：MRC23Q38413 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、73ページ • 納品方法：Eメール（2-3日） • 産業分類：医薬品 |
| Single User | ￥435,000 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥870,000 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界のレチノイド市場について調査・分析し、世界のレチノイド市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（アシトレチン、アダパレン、アリトレチノイン、ベキサロテン、イソトレチオイン、タザロテン、トレチノイン）、用途別セグメント分析（皮膚病、白血病）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、Chongqing Huabang、Cheplapharm Arzneimittel、OLON S.P.A、Siegfried Evionnazなどが含まれています。 世界のレチノイド市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、レチノイド市場規模を推定する際に考慮しました。本レポートは、レチノイドの世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、レチノイドに関するビジネス上の意思決定に役立てることを目的としています。 ・レチノイド市場の概要 - 製品の定義 - レチノイドのタイプ別セグメント - 世界のレチノイド市場規模：タイプ別分析（アシトレチン、アダパレン、アリトレチノイン、ベキサロテン、イソトレチオイン、タザロテン、トレチノイン） - レチノイドの用途別セグメント - 世界のレチノイド市場規模：用途別分析（皮膚病、白血病） - 世界のレチノイド市場規模予測（2018年-2029年） - レチノイドの平均価格推移（2018年-2029年） - 前提条件と制限事項 ・メーカー別競争状況 - メーカー別市場シェア - 世界の主要メーカー、業界ランキング分析 - メーカー別平均価格 - レチノイド市場の競争状況およびトレンド ・レチノイドの地域別市場規模 - 北米のレチノイド市場規模（2018年-2029年） - アメリカのレチノイド市場規模（2018年-2029年） - ヨーロッパのレチノイド市場規模（2018年-2029年） - アジア太平洋のレチノイド市場規模（2018年-2029年） - 中国のレチノイド市場規模（2018年-2029年） - 日本のレチノイド市場規模（2018年-2029年） - 韓国のレチノイド市場規模（2018年-2029年） - インドのレチノイド市場規模（2018年-2029年） - オーストラリアのレチノイド市場規模（2018年-2029年） - 中南米のレチノイド市場規模（2018年-2029年） - 中東・アフリカのレチノイド市場規模（2018年-2029年） ・タイプ別セグメント：アシトレチン、アダパレン、アリトレチノイン、ベキサロテン、イソトレチオイン、タザロテン、トレチノイン - 世界のレチノイドのタイプ別販売量（2018年-2023年） - 世界のレチノイドのタイプ別売上（2018年-2023年） - 世界のレチノイドのタイプ別価格 ・用途別セグメント：皮膚病、白血病 - 世界のレチノイドの用途別販売量（2018年-2023年） - 世界のレチノイドの用途別売上（2018年-2023年） - 世界のレチノイドの用途別価格 ・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向 Chongqing Huabang、Cheplapharm Arzneimittel、OLON S.P.A、Siegfried Evionnaz ・産業チェーンと販売チャネルの分析 - レチノイド産業チェーン分析 - レチノイドの主要原材料 - レチノイドの販売チャネル - レチノイドのディストリビューター - レチノイドの主要顧客 ・レチノイド市場ダイナミクス - レチノイドの業界動向 - レチノイド市場の成長ドライバ、課題、阻害要因 ・調査成果および結論 ・調査方法とデータソース |
The retinoids are a class of chemical compounds that are vitamers of vitamin A or are chemically related to it.
Highlights
The global Retinoids market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Retinoids is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Retinoids is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Retinoids include Chongqing Huabang, Cheplapharm Arzneimittel, OLON S.P.A and Siegfried Evionnaz, etc. in 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Retinoids, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Retinoids.
The Retinoids market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Retinoids market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Retinoids manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Chongqing Huabang
Cheplapharm Arzneimittel
OLON S.P.A
Siegfried Evionnaz
Segment by Type
Acitretin
Adapalene
Alitretinoin
Bexarotene
Isotretionoin
Tazarotene
Tretinoin
Segment by Application
Skin Disease
Leukemia
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Retinoids manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Retinoids in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Retinoids Market Overview
1.1 Product Overview and Scope of Retinoids
1.2 Retinoids Segment by Type
1.2.1 Global Retinoids Market Value Comparison by Type (2023-2029)
1.2.2 Acitretin
1.2.3 Adapalene
1.2.4 Alitretinoin
1.2.5 Bexarotene
1.2.6 Isotretionoin
1.2.7 Tazarotene
1.2.8 Tretinoin
1.3 Retinoids Segment by Application
1.3.1 Global Retinoids Market Value by Application: (2023-2029)
1.3.2 Skin Disease
1.3.3 Leukemia
1.4 Global Retinoids Market Size Estimates and Forecasts
1.4.1 Global Retinoids Revenue 2018-2029
1.4.2 Global Retinoids Sales 2018-2029
1.4.3 Global Retinoids Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Retinoids Market Competition by Manufacturers
2.1 Global Retinoids Sales Market Share by Manufacturers (2018-2023)
2.2 Global Retinoids Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Retinoids Average Price by Manufacturers (2018-2023)
2.4 Global Retinoids Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Retinoids, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Retinoids, Product Type & Application
2.7 Retinoids Market Competitive Situation and Trends
2.7.1 Retinoids Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Retinoids Players Market Share by Revenue
2.7.3 Global Retinoids Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Retinoids Retrospective Market Scenario by Region
3.1 Global Retinoids Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Retinoids Global Retinoids Sales by Region: 2018-2029
3.2.1 Global Retinoids Sales by Region: 2018-2023
3.2.2 Global Retinoids Sales by Region: 2024-2029
3.3 Global Retinoids Global Retinoids Revenue by Region: 2018-2029
3.3.1 Global Retinoids Revenue by Region: 2018-2023
3.3.2 Global Retinoids Revenue by Region: 2024-2029
3.4 North America Retinoids Market Facts & Figures by Country
3.4.1 North America Retinoids Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Retinoids Sales by Country (2018-2029)
3.4.3 North America Retinoids Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Retinoids Market Facts & Figures by Country
3.5.1 Europe Retinoids Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Retinoids Sales by Country (2018-2029)
3.5.3 Europe Retinoids Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Retinoids Market Facts & Figures by Country
3.6.1 Asia Pacific Retinoids Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Retinoids Sales by Country (2018-2029)
3.6.3 Asia Pacific Retinoids Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Retinoids Market Facts & Figures by Country
3.7.1 Latin America Retinoids Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Retinoids Sales by Country (2018-2029)
3.7.3 Latin America Retinoids Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Retinoids Market Facts & Figures by Country
3.8.1 Middle East and Africa Retinoids Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Retinoids Sales by Country (2018-2029)
3.8.3 Middle East and Africa Retinoids Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Retinoids Sales by Type (2018-2029)
4.1.1 Global Retinoids Sales by Type (2018-2023)
4.1.2 Global Retinoids Sales by Type (2024-2029)
4.1.3 Global Retinoids Sales Market Share by Type (2018-2029)
4.2 Global Retinoids Revenue by Type (2018-2029)
4.2.1 Global Retinoids Revenue by Type (2018-2023)
4.2.2 Global Retinoids Revenue by Type (2024-2029)
4.2.3 Global Retinoids Revenue Market Share by Type (2018-2029)
4.3 Global Retinoids Price by Type (2018-2029)
5 Segment by Application
5.1 Global Retinoids Sales by Application (2018-2029)
5.1.1 Global Retinoids Sales by Application (2018-2023)
5.1.2 Global Retinoids Sales by Application (2024-2029)
5.1.3 Global Retinoids Sales Market Share by Application (2018-2029)
5.2 Global Retinoids Revenue by Application (2018-2029)
5.2.1 Global Retinoids Revenue by Application (2018-2023)
5.2.2 Global Retinoids Revenue by Application (2024-2029)
5.2.3 Global Retinoids Revenue Market Share by Application (2018-2029)
5.3 Global Retinoids Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Chongqing Huabang
6.1.1 Chongqing Huabang Corporation Information
6.1.2 Chongqing Huabang Description and Business Overview
6.1.3 Chongqing Huabang Retinoids Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Chongqing Huabang Retinoids Product Portfolio
6.1.5 Chongqing Huabang Recent Developments/Updates
6.2 Cheplapharm Arzneimittel
6.2.1 Cheplapharm Arzneimittel Corporation Information
6.2.2 Cheplapharm Arzneimittel Description and Business Overview
6.2.3 Cheplapharm Arzneimittel Retinoids Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Cheplapharm Arzneimittel Retinoids Product Portfolio
6.2.5 Cheplapharm Arzneimittel Recent Developments/Updates
6.3 OLON S.P.A
6.3.1 OLON S.P.A Corporation Information
6.3.2 OLON S.P.A Description and Business Overview
6.3.3 OLON S.P.A Retinoids Sales, Revenue and Gross Margin (2018-2023)
6.3.4 OLON S.P.A Retinoids Product Portfolio
6.3.5 OLON S.P.A Recent Developments/Updates
6.4 Siegfried Evionnaz
6.4.1 Siegfried Evionnaz Corporation Information
6.4.2 Siegfried Evionnaz Description and Business Overview
6.4.3 Siegfried Evionnaz Retinoids Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Siegfried Evionnaz Retinoids Product Portfolio
6.4.5 Siegfried Evionnaz Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Retinoids Industry Chain Analysis
7.2 Retinoids Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Retinoids Production Mode & Process
7.4 Retinoids Sales and Marketing
7.4.1 Retinoids Sales Channels
7.4.2 Retinoids Distributors
7.5 Retinoids Customers
8 Retinoids Market Dynamics
8.1 Retinoids Industry Trends
8.2 Retinoids Market Drivers
8.3 Retinoids Market Challenges
8.4 Retinoids Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer